CRH Investors Logo

CRH Medical Announces Date for First Quarter 2015 Results and Conference Call

VANCOUVER, B.C. – April 24, 2015 – CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company that provides physicians with innovative products for the treatment of gastrointestinal diseases, today announced that it plans to release its financial results for the first quarter ended March 31, 2015, at 8:30 am ET on Wednesday, April 29, 2015.

A telephone conference call hosted by management to discuss the financial results will be held on Wednesday, April 29, 2015 at 10 am ET.

The telephone numbers for the conference call are (888) 231-8191 or (647) 427-7450.

At the call’s completion, an audio replay will be available by calling (855) 859-2056 or (416) 849-0833 and using passcode 36237049. The phone replay will be available until May 13, 2015.

About CRH Medical Corporation:

CRH Medical Corporation is a North American company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases. The Company’s product distribution strategy focuses on physician education, patient outcomes, and patient awareness. The Company’s first product, the CRH O’Regan System, is a single use, disposable, hemorrhoid banding technology that is safe and highly effective in treating hemorrhoid grades I – IV. CRH distributes the CRH O’Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians, allowing CRH to create meaningful relationships with the physicians it serves. CRH also operates full service gastroenterology anesthesia services businesses, which provide anesthesia services for patients undergoing endoscopies and colonoscopies. Performing these procedures under anesthesia makes these procedures more comfortable for patients and allows gastroenterologists to perform more procedures than in the absence of anesthesia. CRH expects to leverage the capabilities it acquired through these gastroenterology anesthesia companies to consolidate the highly fragmented gastroenterology anesthesia provider business. The Company’s goal is to establish CRH as the premier provider of innovative products and essential services to gastroenterologists throughout the United States.

The common shares of CRH trade on the Toronto Stock Exchange as ticker ‘CRH’. For more information visit our website at
For more information, please contact:

David Matousek, Director Investor Relations
CRH Medical Corporation
604.633.1440 x1030

– Or –

Edward Wright, Chief Executive Officer
CRH Medical Corporation
604.633.1440 x1008